Matthew D. Linnik
Nessuna posizione attualmente
Profilo
Matthew D.
Linnik joined La Jolla Pharmaceutical Co. in 1998 as Director of Research and Development and was appointed Vice President of Research in February 1999, Executive Vice President of Research in June 1999, Chief Scientific Officer and Executive Vice President of Research in 2002 and Assistant Secretary in 1999.
Previously, he was Senior Pharmacologist, Scientist, Research Scientist and Project Leader of Hoechst Marion Roussel from 1989 to 1998, Adjunct Associate Professor of Neurosurgery at the University of Cincinnati School of Medicine from 1996 to 1998 and Postdoctoral Fellow and Instructor in the Departments of Neurology and Neurosurgery at Massachusetts General Hospital and the Harvard Medical School from 1986 to 1988.
Dr. Linnik received a BA degree in Physiology from Southern Illinois University and a PhD in Physiology and Pharmacology from the Southern Illinois University School of Medicine.
Precedenti posizioni note di Matthew D. Linnik
Società | Posizione | Fine |
---|---|---|
LA JOLLA PHARMACEUTICAL COMPANY | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Matthew D. Linnik
Southern Illinois University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
La Jolla Pharmaceutical Co.
La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Matthew D. Linnik